These genetic alterations typically lead to the aberrant activation of two main signalling pathways in melanoma: the RAS/RAF/MEK/ERK signalling cascade [also known as the mitogen-activated protein kinase (MAPK) pathway] and the phosphoinositol-3-kinase (PI3K)/AKT pathway [11]. Here, MAP2K7 is linked to melanoma.